CAIRDAC, a France-based medical technology company developing a leadless, self-powered cardiac pacemaker, has appointed Raymond W. Cohen as Chairman of its Board of Directors. Cohen brings more than ...

Karen Carlson has long played an active role in her Maryland community. In the mornings, her neighbors would see her out on her daily run. On the weekends, she would mow her elderly neighbors’ lawns.

Axonics Inc revolutioniert die Behandlung von Harninkontinenz mit innovativen Implantaten – ein Markt mit enormem Potenzial. Für dich als Anleger weltweit: Erfahre, warum diese US-Aktie in deinem ...

Alle reden drüber, kaum jemand checkt wirklich, was dahintersteckt: Axonics Inc mischt gerade Medizin-Tech, Social Media und Börse gleichzeitig auf. Klingt wild – ist es auch. Aber: Lohnt sich das?

Axis Research is one of OC’s only bioskills training facilities At its Irvine facility, Axis Research & Technologies provides top-tier bioskills training for some of the medtech industry’s most ...

Biomedical engineers at Duke University have demonstrated a new nerve stimulation technique that relieves constipation. By stimulating the sacral nerve using a pattern of electrical bursts, the team ...

RxSight, Inc. (NASDAQ: RXST) announced the appointment of Raymond W. Cohen to its board of directors. The Aliso Viejo, California-based ophthalmic medical device company specializes in customized ...

The following is a summary of “A prospective feasibility study to differentiate sacral neuromodulation lead electrode configurations using motor and sensory thresholds and locations of sensation,” ...

Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and macroeconomic concerns are major dampeners. The stock carries a Zacks Rank ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific Corporation plans to acquire Axonics, Inc. for $3.7 billion in cash to expand its urology offerings with Axonics' innovative urinary and bowel disorder treatments. Axonics, founded ...